- Bend Bulletin main site
- Bend Bulletin archives
- Terms of Use
- Privacy Policy
- Contact the Bulletin
- Comments/Questions?
Published daily in Bend, Oregon, by Western Communications, Inc. Copyright 2007.
November 9, 2011
NEW YORK — Amylin Pharmaceuticals and Eli Lilly said Tuesday that they have agreed to end a decadelong diabetes partnership to resolve litigation between the two drugmakers.
Amylin will assume global responsibility for developing the injectable drug Byetta and win rights to Bydureon, a....
